Summary The expression of c-myc protein was studied in primary cultures of rat hepatocytes and rat liverderived epithelial cell lines. The levels of the protein were determined by flow cytometry using a monoclonal antibody to the c-myc protein. Freshly isolated hepatocytes from normal adult male Fischer F344 rats had low but detectable levels of the protein which were similar in the different ploidies. Higher levels were detected in immortalised but untransformed rat liver cell lines, and increased expression was observed during passage through the cell cycle. Following in vitro transformation of one of the immortalised epithelial cell lines by ras genes, similar levels of c-myc expression to those present in the untransformed cells was maintained. Transformation by activated aflatoxin B1 (AFB1) resulted in lower levels of expression. The cell cycle related level of expression was also seen in the transformed cells. Similar results to those observed in the in vitro ras transfected liver-derived cell lines were obtained from in vivo AFB1-induced rat hepatoma cell lines. These results demonstrate that continuously dividing rat liver-derived cell lines have higher levels of expression of c-myc protein than non-dividing, freshly isolated hepatocytes, and that there is no further elevation in the levels observed when these cell lines are transformed. In some cases decreased levels can result from malignant transformation.
An alteration in the expression of cellular oncogenes has been found to accompany neoplastic transformation, both in vivo and in vitro. Most of the oncogenes for which the mechanism of action has been examined have been shown to be involved in the processes controlling cell division and differentiation. Alteration of oncogene expression presumably leads to the deregulation of these processes, which results in the altered growth properties of the neoplastic cell.
There is evidence that the c-myc oncogene has a role in cell proliferation. The c-myc protein is associated with the nucleus (Evan & Hancock, 1986 ) and DNA synthesis is inhibited by antibodies to the c-myc protein (Studzinski et al., 1986) . In an in vivo malignancy there are many differences from normal tissues including uncontrolled cell proliferation, invasiveness and the property to metastasise, and frequently a heterogenous population of cells is present. Therefore, in the present study, cells with well defined characteristics were used to study the expression of c-myc protein in primary hepatocytes and both transformed and untransformed rat liver-derived cell lines.
In previously reported studies on rat liver, the c-myc m-RNA has been found to be increased following partial hepatectomy (Makino et al., 1984a; Thompson et al., 1986) , and is also increased in primary hepatocytes in culture in response to growth factors (Kruiger et al., 1986) . Following the administration of hepatocarcinogens it has been found to be elevated in the tumorous portions of liver of rats as compared to the non-tumorous portion (Makino et al., 1984b; Cote et al., 1985) . However, here again, because of the heterogeneous nature of the tissue and the possible presence of both toxic and preneoplastic changes in liver which is apparently 'normal', it is difficult to define precisely the cellular composition of the tissues.
The (Berry & Friend, 1962) . Cells were fixed immediately after isolation in 50% methanol in PBS. Immortalised but untransformed rat liver-derived epithelial cell lines (BL8 and BL9) were previously derived by spontaneous immortalisation of cells from primary cultures of hepatocytes (Manson et al., 1981) . These are continuously dividing cell lines but are contact inhibited, non-tumorigenic in nude mice and do not show anchorage independent growth. On transformation of BL8 cells either by transfection with cloned ras oncogenes (Sinha et al., 1986) or by aflatoxin B1 (AFB1) in vitro (Sinha et al., 1987a) these cell lines show the induction of biochemical markers specific for liver cell transformation (elevated gamma-glutamyl transferase and glutathione S-transferase P levels) and can reproduce a range of the phenotype paralleling that seen in experimental rat hepatomas in vivo (Sinha et al., 1987b) . On cotransfection with ras oncogene along with G418 resistant markers, a number of G418 resistant cell lines were obtained which are untransformed, presumably because of the inappropriate or inadequate expression of the oncogene product. These untransformed derivatives of the cell line BL8 were cloned and acted as further controls for their transformed counterparts. Other cells used in this study were two lines derived in this laboratory from in vivo AFB1 induced rat liver tumours (JBI and BLIO) and the Morris Hepatoma (HTC) cell line (Morris et al., 1978) which is known to possess high expression of c-myc.
Staining for c-myc-product
Antibody to c-myc (MYC 1-6E10) was kindly made available by G. Evan (MRC, Cambridge) . This is a c-myc AND LIVER-DERIVED EPITHELIAL CELLS 675 monoclonal antibody to the 62 kD protein initially raised in Balb/C mice against a synthetic peptide. The flow cytometric assay for c-myc was essentially based on the procedure described by Watson et al. (1985) . Replicate samples of cultured cells in log phase were detached by trypsin/EDTA (0.05% w/v, 0.5 mM in PBS), washed in phosphate buffered saline (PBS) and fixed in 50% methanol in PBS. Fixed cells were stored at 4°C for periods of up to 2 weeks. About 1 x 106 cells were then resuspended in 6 ml PBS and aliquots dispensed into Eppendorf tubes. Cells were centrifuged for 4 min and the supernatant was aspirated. The cell pellet was then resuspended in 10 1l of the antibody (1O x concentrated hybridoma culture supernatant) at dilutions of 1:10, 1:31.6, 1:100 and 1:316 while PBS was used for the control. Cells were incubated with the antibody for 60 min at room temperature and washed once with 0.5 ml PBS. Cells were then incubated with rabbit antimouse antibody conjugated to FITC (Dacopatts Immuno) diluted 1:20 in PBS. Cells were incubated with the second antibody for 60 min, washed with PBS and resuspended in 0.5 ml of PBS containing propidium iodine (PI) (0.05 mg ml-1) and RNase. Each series of samples had two controls, cells stained with PI alone and cells containing PI and the second antibody alone. Flow cytometry for such cells has been described by Watson et al. (1985) . The quantitation of c-myc protein by this method is semi-quantitative and is expressed in arbitrary fluorescence units. This semi-quantitation permits valid comparisons to be made between levels in the different cell lines. The red fluorescence, due to PI staining of the DNA, indicated the DNA status of the individual cells and hence the position in the cell cycle, while the specific cmyc staining was indicated by green fluorescence due to the presence of the FITC-labelled second antibody. Mean fluorescence values were determined as described by Smith et al. (1985) . Figure 1 c-myc specific green fluorescence in three samples of freshly isolated hepatocytes (isolated points A, 0 and V) and in the two rat liver-derived cell lines BL8 (M-M) and BL9 (0-0). The diploid (2n) and tetraploid/binucleate (4n) populations of rat hepatocytes are represented, while for the cell lines the c-myc levels are for the G1, S and G2 points of the cell cycle.
Results
The expression of c-myc protein by the cells was assayed using a monoclonal antibody to the protein as the primary antibody, an FITC-conjugated second antibody and the Cambridge MRC multiparameter flow cytometer (Watson, 1987) . The median green fluorescence channel was used to quantify the amount of c-myc in the individual samples. Fluorescence levels were measured in all samples at different concentrations of antibody and the optimum concentrations of the antibody determined for use in the quantification. Freshly isolated hepatocytes had extremely low levels of c-myc protein. On the basis of the PI stain, three populations of cells were observed on the red fluorescence axis which were identified as diploid, tetraploid and diploid binucleates (which could not be distinguished from mononucleate tetraploids) and octaploid. Adult rat hepatocytes have an extremely low mitotic index and S-phase cells were not detected (Figure 1) .
The two immortalised but untransformed rat liver cell lines BL8 and BL9 expressed different levels of c-myc protein, both of which were considerably higher than those present in three samples of freshly isolated hepatocytes (Figure 1) . One of the tumorigenic derivatives of the BL8 cells ( Figure 2 ) transfected with activated ras oncogenes and two BL8 derived cell lines transfected with PSV2 neo Ha-ras (Sinha et al., 1986) and exhibiting neomycin resistance but non-tumorigenic (Figure 2 ) had c-myc levels which were similar. The BL8 derived cell line transformed in vitro with activated AFB1 had lower levels of c-myc expression ( Figure  2 ). Cell lines JB1 and BL1O (from in vivo tumours) again expressed c-myc at a similar level to that seen in the BL8 parent line. HTC, the Morris hepatoma cell line which is known to have a high level of c-myc expression, exhibited values in excess of those observed using the other cell lines ( Figure 2) . In all the cell lines, c-myc levels were cell cycle dependent, increasing from GI through S to G2. In general, within a given cell line, the c-myc levels had a linear relationship with the amount of DNA in any phase of the cell cycle.
Discussion
It is possible to observe the distinction between cell proliferation and transformation in in vitro systems much more clearly than in most in vivo models of carcinogenesis. The experimental in vitro phenotypic indicators of cell transformation, e.g. anchorage independent growth, loss of contact inhibition and tumorigenicity in nude mice, are able to distinguish a transformed cell from an immortalised or dividing cell, especially when taken in conjunction with each other. The cell lines used in this study included derivatives of the BL8 cell line which had been transformed by N-ras and Ha-ras as well as by AFB1 in vitro. The AFB1 transformed cell line has been shown to contain an activated Ha-ras gene, and the cell lines JBI and BL0 from in vivo tumours contain activated N-ras genes (Sinha et al., 1987b) . There was a variation in the c-myc content between the individual cell lines, and the reasons for this are not clear. c-myc expression levels were found to be higher in all the continuously dividing cell lines as compared to the nondividing hepatocytes. The transformed cell lines did not have elevated c-myc levels compared with untransformed cells and in one case of cell transformation (with activated AFB1) there appeared to be reduced expression of the c-myc protein.
Although the hepatoma cell line HTC is a known cmyc over-producer, one of the untransformed derivatives of the BL8 was found to have levels of the protein approaching those of the HTC line. Using homogenous cell populations as in the present study, it is easier to examine the association between the c-myc oncogene levels and other growth properties.
A cell cycle dependent change in the levels of the c-myc gene product was also clearly demonstrated in the study, the levels increasing from GI through S to G2 and closely paralleling the increase in the DNA content of the cell line being studied. In contrast the levels in non-dividing hepatocytes were found to be low even in those populations possessing higher ploidies. The cell cycle dependent increase in the c-myc values in the case of the liver-derived epithelial cell lines differs from the observations on fibroblastic 3T3 cells (Rabbits et al., 1985) . The reasons for this difference between the two cell lines are not known. The results of this study, considered in the light of two stages believed to be involved in the chemically induced malignant transformation of cells, namely immortalisation and oncogene activation, strongly support the involvement of elevated myc expression in the former process but not in the latter. It is intended to examine this parameter in the in vivo situation, which may help to determine the sequence in which the 'mutational' events occur in in vivo aflatoxin-induced carcinogenesis in rat liver.
